NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Kirill Starostin
Sanofi US - New Jersey / United States
Others
AD Scientific Index ID: 5602474
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Kirill Starostin's MOST POPULAR ARTICLES
1-)
Comparative safety of bevacizumab, ranibizumab, and aflibercept for treatment of neovascular age-related macular degeneration (AMD): a systematic review and network meta …AA Plyukhova, MV Budzinskaya, KM Starostin, R Rejdak, C Bucolo, ...Journal of clinical medicine 9 (5), 1522, 2020732020
2-)
Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities …IV Maev, AA Samsonov, LK Palgova, CS Pavlov, EN Shirokova, EI Vovk, ...BMJ open gastroenterology 7 (1), e000368, 2020372020
3-)
Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)IV Maev, AA Samsonov, LK Palgova, CS Pavlov, EI Vovk, EN Shirokova, ...BMJ Open Gastroenterology 7 (1), e000341, 2020362020
4-)
Prospects for using gold, silver, and iron oxide nanoparticles for increasing the efficacy of chemotherapyTA Fedotcheva, AY Olenin, KM Starostin, GV Lisichkin, VV Banin, ...Pharmaceutical Chemistry Journal 49, 220-230, 2015292015
5-)
Regression of liver steatosis following phosphatidylcholine administration: a review of molecular and metabolic pathways involvedD Osipova, K Kokoreva, L Lazebnik, E Golovanova, C Pavlov, A Dukhanin, ...Frontiers in Pharmacology 13, 797923, 2022242022
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept